Spring 2021 rotator: images of flowers and storm clouds on the NCI at Frederick campus
Rotator commemorating NCI at Frederick's 50th anniversary: black-and-white images of scientists and staff working at the facility and meeting with other scientists
Winter 2021 rotator: images of snow, icicles, and holly at NCI at Frederick
Science in Frederick rotator: images of devices and scientists performing experiments

Monday, June 7, 2021

George Vande Woude, Ph.D., former director of the Advanced Bioscience Laboratories–Basic Research Program at what is now NCI at Frederick, passed away in April. He was known for being a prudent leader and an outstanding scientist (he and his laboratory discovered the MET oncogene in 1984), as well as for his vibrant personality and seemingly limitless energy.

Thursday, April 29, 2021

The past year for Ligia Pinto, Ph.D., and her staff has been full of pressure and remote meetings at all hours of the day and night. It’s also been one of partnerships and progress. Pinto heads the Vaccine, Immunity, and Cancer Directorate, the group at the Frederick National Laboratory that’s leading the national SARS-CoV-2 Serological Sciences Network (SeroNet). At this time last year, her laboratories, which specialized in human papillomavirus, antibody science, and serology, had just been asked to help the Food and Drug Administration evaluate the quality of the new SARS-CoV-2 antibody tests that were flooding the market.

Wednesday, April 28, 2021

The CCR community is profoundly saddened by the recent passing of George Vande Woude, Ph.D., longtime National Cancer Institute (NCI) colleague, former director of the Advanced Bioscience Laboratories (ABL)-Basic Research Program and former director of the Division of Basic Sciences at NCI. George made many important contributions to the current understanding of the molecular biology of cancer.

Tuesday, April 27, 2021

Though it lasted just 15 years, Frederick’s first clinical oncology program answered multiple fundamental questions in the fledgling field of immunotherapy and primed the local medical community to become the oncology research hub it is today. The Biological Response Modifiers Program (BRMP) received formal recognition from the Department of Health and Human Services 40 years ago today, on April 27.

Thursday, April 22, 2021

Researchers have found a potential therapeutic target for lung squamous cell carcinoma (LSCC), the second most prevalent type of lung cancer. This may pave the way for a targeted therapy for LSCC, which currently has no approved targeted therapies.

Subscribe to Poster

The subscriber's email address.

Dates to Note

Upcoming Holidays

Veterans Day
November 11, 2021

Thanksgiving
November 25, 2021

Christmas
December 25, 2021

New Year's Day
January 1, 2022

Martin Luther King, Jr. Day
January 17, 2022

President's Day
February 21, 2022

Memorial Day
May 30, 2022

Juneteenth
June 19, 2022

Independence Day
July 4, 2022

Labor Day
September 5, 2022